| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director | 10% Owner +1 more
24 companies
Perceptive Advisors LLC is a 10% Owner at FOLD, with reported holdings spanning 24 companies. Recent filings cover 133 purchases and 47 sales. Those positions are worth an estimated $1.0B at current prices.
Our model assigns Perceptive Advisors LLC a middling insider score of 51/100, based on 88 past trades. Over a 12-month horizon, 44.9% of those trades were profitable, with an average 12-month return of -6.3%.
Perceptive Advisors LLC's largest disclosed position is in FOLD as 10% Owner, worth about $263.0M. Net of sales, the recent Form 4 record there shows accumulation of 2,735,827 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | IMTX Immatics N.V. | Director | Buy | 863,060 | $8.69 | $7,499,991.40 | +8.3% | - | - | |
| Nov 13, 2025 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 45,875 | $3.98 | $182,515.31 | -76.6% | -64.1% | - | |
| Nov 10, 2025 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 70,390 | $4.89 | $344,219.10 | -79.0% | -65.5% | - | |
| Aug 1, 2025 | OBIO Orchestra Biomed Holdings, Inc. | 10% Owner | Buy | 700,000 | $2.75 | $1,925,000.00 | +15.2% | +64.3% | +63.1% | |
| May 1, 2025 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 736,767 | $1.38 | $1,017,919.45 | -19.2% | -0.8% | +57.1% | |
| Apr 29, 2025 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 1,519,952 | $1.81 | $2,744,946.03 | -28.4% | -0.7% | - | |
| Apr 3, 2025 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Sell | 3,400,000 | $1.42 | $4,828,000.00 | -36.7% | +181.7% | +16.9% | |
| Feb 19, 2025 | SLDB Solid Biosciences Inc. | Director, 10% Owner | Buy | 5,000,000 | $4.03 | $20,150,000.00 | +73.2% | -54.4% | -9.1% | |
| Aug 12, 2024 | MGTX Meiragtx Holdings Plc | Director, 10% Owner | Buy | 1,250,000 | $4.00 | $5,000,000.00 | +11.1% | +77.5% | +100.5% | |
| Apr 11, 2024 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Buy | 2,353,000 | $8.50 | $20,000,500.00 | +78.2% | -22.9% | -82.6% |